At the conclusion of the activity, the participant should be able to:
Provide advice to patients who inquire about the potential of gene and cell therapy or the availability of open clinical trials, based on their exposure to the current clinical trials in gene and cell therapies.
Better instruct their students in medical school and other health venues using the state-of-the-art basic science and clinical trials data presented at the meeting.
Use the latest advances in gene and cell therapy to enhance their research mission, as physician scientists conducting basic and clinical research.
Demonstrate improved regulatory compliance in conducting gene and cell therapy clinical trials, through exposure to NIH and FDA faculty during the educational program.
Please answer the following by checking a number. Your feedback is needed and greatly appreciated by the Society.